CHENGDU OLYMVAX BIOPHARMACEUTICALSCHENGDU OLYMVAX BIOPHARMACEUTICALSCHENGDU OLYMVAX BIOPHARMACEUTICALS

CHENGDU OLYMVAX BIOPHARMACEUTICALS

No trades
See on Supercharts

688319 fundamentals

CHENGDU OLYMVAX BIOPHARMACEUTICALS revenue breakdown overview

CHENGDU OLYMVAX BIOPHARMACEUTICALS revenue for the last year amounted to 496.06 M CNY, the most of which — 462.96 M CNY — came from its highest performing source at the moment, Adsorbed Tetanus Vaccine, the year earlier bringing 437.65 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought CHENGDU OLYMVAX BIOPHARMACEUTICALS 496.12 M CNY, and the year before that — 547.48 M CNY.

By source
By country